Clinical trialObservationalCompleted
INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors
- Outcome
- Finished, no results posted
- Phase
- Observational
- Status
- Completed
- Study type
- Observational
- Start
- 2 February 2021
- Ended
- 22 February 2025
- Enrollment
- 342 participants
- Sites
- 1
- Primary outcomes
- Relationship between known prognostic histological markers of pancreatic adenocarcinoma and patient survival.
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 30 March 2025
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The study is particularly innovative as it will accurately analyze the microscopic characteristics of the stroma, tumor budding and mucin expression in adenocarcinomas of the pancreas, using a comparative approach of long-survivor/short-survival patients.